Changeflow GovPing Pharma & Drug Safety USPTO Patent Grant US12583831B2 for Hydrogenati...
Routine Rule Added Final

USPTO Patent Grant US12583831B2 for Hydrogenation Processes

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has granted patent US12583831B2 to Archer-Daniels-Midland Company for selective hydrogenation processes and catalysts. The patent covers methods for upgrading impure feedstocks, such as those derived from biomass, to increase the concentration of valuable intermediates like glycolaldehyde and hydroxyacetone.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO patent grant US12583831B2 has been issued to Archer-Daniels-Midland Company, covering novel processes and catalysts for the selective hydrogenation of compounds with carbonyl carbon atoms. The patent specifically addresses methods to upgrade impure feedstocks, particularly those derived from biomass, to enhance the concentration of desired intermediates like glycolaldehyde and hydroxyacetone without over-hydrogenation. The disclosed technology utilizes noble metal catalysts, such as Ruthenium (Ru) and Platinum (Pt), to achieve this selectivity.

This patent grant represents a new intellectual property protection for specific chemical processes. While it does not impose direct compliance obligations on other entities, it may influence research and development strategies, licensing opportunities, and competitive landscapes within the chemical and pharmaceutical manufacturing sectors. Companies operating in related fields should be aware of this patented technology, particularly if their processes involve biomass conversion or selective hydrogenation of carbonyl compounds.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Processes and cataylsts for the selective hydrogenation of compounds having carbonyl carbon atoms

Grant US12583831B2 Kind: B2 Mar 24, 2026

Assignee

ARCHER-DANIELS-MIDLAND COMPANY

Inventors

James Brazdil, Chi-Cheng Ma

Abstract

Selective hydrogenation processes are disclosed that can upgrade impure feeds, such as those obtained from biomass and containing a number of small (e.g., 2-6 carbon atom) molecules having aldehyde and/or ketone carbon atoms. For example, whereas glycolaldehyde and its methylated derivative, hydroxyacetone (acetol) are both high value intermediates for certain downstream processing reactions, they are normally recovered in a condensate from pyrolysis of carbohydrates (e.g., aldose-containing sugars) together with glyoxal and its methylated derivative, pyruvaldehyde. The selective hydrogenation of these compounds bearing two carbonyl carbon atoms, without over-hydrogenation to ethylene glycol and propylene glycol, can increase the concentration of the desired intermediates. These beneficial effects of selective hydrogenation may be achieved through the use of a hydrogenation catalyst comprising noble metals such as Ru and Pt.

CPC Classifications

C07C 45/64 C07D 307/42

Filing Date

2024-07-17

Application No.

18775179

Claims

17

View original document →

Named provisions

Processes and cataylsts for the selective hydrogenation of compounds having carbonyl carbon atoms

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12583831B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3241 Chemical Manufacturing 3254.1 Biotechnology
Activity scope
Chemical Synthesis Biomass Conversion
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Topics
Chemical Manufacturing Biotechnology

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!